His scientific interests lie mostly in Pulmonary hypertension, Internal medicine, Cardiology, Pulmonary artery and Anesthesia. The various areas that Robert Naeije examines in his Pulmonary hypertension study include Respiratory disease, Doppler echocardiography, Vascular resistance, Blood pressure and Bosentan. He frequently studies issues relating to Endocrinology and Internal medicine.
His research investigates the connection with Cardiology and areas like Surgery which intersect with concerns in Treprostinil, Clinical trial and Physical exercise. His biological study spans a wide range of topics, including Hypoxemia, Endothelin 1, Clinical endpoint, Cardiac index and Pulmonary function testing. His Anesthesia research is multidisciplinary, relying on both Mean arterial pressure and Altitude sickness.
His primary scientific interests are in Internal medicine, Cardiology, Pulmonary hypertension, Anesthesia and Pulmonary artery. His Internal medicine study often links to related topics such as Endocrinology. His work deals with themes such as Surgery and Lung, which intersect with Cardiology.
His Pulmonary hypertension research incorporates elements of Respiratory disease, Ventricle, Doppler echocardiography, Stroke volume and Intensive care medicine. While the research belongs to areas of Anesthesia, Robert Naeije spends his time largely on the problem of Hypoxia, intersecting his research to questions surrounding Hyperoxia. The subject of his Hypoxic pulmonary vasoconstriction research is within the realm of Vasoconstriction.
Internal medicine, Cardiology, Pulmonary hypertension, Vascular resistance and Pulmonary artery are his primary areas of study. His Internal medicine study deals with Endocrinology intersecting with Endothelin receptor. All of his Cardiology and Cardiac output, Heart failure, Afterload, Stroke volume and Ventricle investigations are sub-components of the entire Cardiology study.
The concepts of his Pulmonary hypertension study are interwoven with issues in Doppler echocardiography, Pulmonary wedge pressure, Central venous pressure and Ventricular function. His Vascular resistance research focuses on VO2 max and how it connects with Exercise capacity. His Hemodynamics research incorporates themes from Lung and Cardiac catheterization.
Robert Naeije mainly focuses on Internal medicine, Cardiology, Pulmonary hypertension, Vascular resistance and Pulmonary artery. Cardiology is a component of his Cardiac output, Hemodynamics, Pulmonary wedge pressure, Stroke volume and Ventricle studies. His studies deal with areas such as Heart failure, MEDLINE, Intensive care medicine, Ventricular arterial coupling and Magnetic resonance imaging as well as Pulmonary hypertension.
His work carried out in the field of Vascular resistance brings together such families of science as Central venous pressure, Doppler echocardiography, VO2 max and Exercise capacity. His Pulmonary artery research includes elements of Overweight, Ventricular contraction, Cardiac imaging, Acute respiratory distress and Oxygen pressure. Robert Naeije combines subjects such as Exercise stress echocardiography and Flow with his study of Anesthesia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Inhaled iloprost for severe pulmonary hypertension.
Horst Olschewski;Gerald Simonneau;Nazzareno Galiè;Timothy Higenbottam.
The New England Journal of Medicine (2002)
Diagnosis and Assessment of Pulmonary Arterial Hypertension
David B. Badesch;Hunter C. Champion;Miguel Angel Gomez Sanchez;Marius M. Hoeper.
Journal of the American College of Cardiology (2009)
Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial.
Nazzareno Galie;Marc Humbert;Jean-Luc Vachiery;Carmine Dario Vizza.
Journal of the American College of Cardiology (2002)
Right Heart Adaptation to Pulmonary Arterial Hypertension: Physiology and Pathobiology
Anton Vonk-Noordegraaf;François Haddad;Kelly M. Chin;Paul R. Forfia.
Journal of the American College of Cardiology (2013)
Treatment of Pulmonary Arterial Hypertension With the Selective Endothelin-A Receptor Antagonist Sitaxsentan
Robyn J. Barst;David Langleben;David B. Badesch;Adaani Frost.
Journal of the American College of Cardiology (2006)
Ambrisentan Therapy for Pulmonary Arterial Hypertension
Nazzareno Galié;David Badesch;Ronald Oudiz;Gérald Simonneau.
Journal of the American College of Cardiology (2005)
Pulmonary hypertension in COPD
Ari Chaouat;Robert Naeije;E Weitzenblum.
European Respiratory Journal (2008)
High-Altitude Pulmonary Edema Is Initially Caused by an Increase in Capillary Pressure
Marco Maggiorini;Christian Mélot;Sebastien Pierre;Fredi Pfeiffer.
Circulation (2001)
SYSTEMIC AND PULMONARY HAEMODYNAMIC EFFECTS OF SOMATOSTATIN
R Hallemans;R Naeije;C Melot;P Mols.
The Lancet (1981)
Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension
Marius M. Hoeper;Joan Albert Barberà;Richard N. Channick;Paul M. Hassoun.
Journal of the American College of Cardiology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Salerno
University of Giessen
University of Paris-Saclay
University of Giessen
Hannover Medical School
University of Paris-Saclay
Newcastle University
University of Bologna
Medical University of Graz
OLV Hospital
Tel Aviv University
University of California, Santa Cruz
Yahoo! Research
University College London
University of Ottawa
Universiti Brunei Darussalam
Maastricht University
University of Calgary
University of Oxford
Cleveland Clinic
Norwegian University of Science and Technology
Aristotle University of Thessaloniki
University of Florida
University of Toronto
Space Telescope Science Institute
Spanish National Research Council